Board MeetingOutcome of Board Meeting
Morepen Labs' board approved financial results for the quarter and half-year.
Morepen Laboratories LimitedMOREPENLAB · Filed with the exchange
Consolidated Net Profit for H1 FY26 was Rs 51.62 Cr.
The company booked a Rs 25.83 Cr exceptional gain from Dr. Morepen Ltd ceasing to be a subsidiary.
No comments yet. Be the first.